Oscar Health Files 8-K on Financial Condition
Ticker: OSCR · Form: 8-K · Filed: Jan 10, 2024 · CIK: 1568651
Complexity: simple
Sentiment: neutral
Topics: financial-condition, 8-K, corporate-update
TL;DR
**Oscar Health just filed an 8-K about its financials, so expect more details soon.**
AI Summary
Oscar Health, Inc. filed an 8-K on January 10, 2024, to report on its results of operations and financial condition. This filing is a standard procedural update, indicating that the company is providing current information to the SEC, likely in preparation for or in conjunction with a public announcement. For investors, this matters because it signals that new financial information is being disclosed, which could impact the stock price depending on the nature of the results.
Why It Matters
This filing indicates Oscar Health is updating the market on its financial performance, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial condition, not indicating any immediate negative or positive event.
Analyst Insight
A smart investor would monitor Oscar Health's upcoming announcements for the specific financial results mentioned in this 8-K to understand the company's performance.
Key Numbers
- 001-40154 — Commission File Number (identifies Oscar Health's filings with the SEC)
- 2024-01-10 — Date of Report (the date the earliest event reported in the 8-K occurred)
Key Players & Entities
- Oscar Health, Inc. (company) — the registrant filing the 8-K
- Delaware (company) — state of incorporation for Oscar Health, Inc.
- New York Stock Exchange (company) — exchange where Oscar Health's Class A Common Stock is registered
- OSCR (company) — trading symbol for Oscar Health's Class A Common Stock
Forward-Looking Statements
- Oscar Health will release detailed financial results soon. (Oscar Health, Inc.) — high confidence, target: Q1 2024
FAQ
What is the purpose of this 8-K filing by Oscar Health, Inc.?
The purpose of this 8-K filing by Oscar Health, Inc. is to report on 'Results of Operations and Financial Condition' as of January 10, 2024, under Item 2.02.
What is Oscar Health, Inc.'s trading symbol and on which exchange is its stock registered?
Oscar Health, Inc.'s trading symbol is OSCR, and its Class A Common Stock is registered on the New York Stock Exchange.
What is the business address of Oscar Health, Inc. as stated in the filing?
The business address of Oscar Health, Inc. is 75 Varick Street, 5th Floor, New York, New York 10013.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 10, 2024.
What is the state of incorporation for Oscar Health, Inc.?
Oscar Health, Inc. is incorporated in Delaware.
Filing Stats: 969 words · 4 min read · ~3 pages · Grade level 13.6 · Accepted 2024-01-10 06:07:52
Key Financial Figures
- $0.00001 — which registered Class A Common Stock, $0.00001 par value per share OSCR New York S
Filing Documents
- d581645d8k.htm (8-K) — 27KB
- 0001193125-24-005574.txt ( ) — 146KB
- oscr-20240110.xsd (EX-101.SCH) — 3KB
- oscr-20240110_lab.xml (EX-101.LAB) — 18KB
- oscr-20240110_pre.xml (EX-101.PRE) — 11KB
- d581645d8k_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. 2023 Outlook Affirmation Oscar Health, Inc. (the "Company") will participate in the 42nd Annual J.P. Morgan Healthcare Conference (the "JPM Conference") on January 10, 2024. At the JPM Conference, the Company will reaffirm the updated full year 2023 guidance that it provided in its financial results press release for the third quarter of 2023 dated November 7, 2023. The Company will also reaffirm its target of Total Company Adjusted EBITDA profitability in 2024 and provide an interim update on membership from the 2024 open enrollment period. The Company expects to present at the JPM Conference at approximately 9:00 AM PT (12:00 PM ET), and the presentation will be available through a virtual webcast. Materials related to the presentation will be posted on the investor relations page of the Company's website (ir.hioscar.com) following the webcast, along with instructions for accessing the webcast (as previously provided through a news wire release on December 20, 2023). This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing. Cautionary Note Regarding Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our expected financial performance and upcoming events and presentations. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are di
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Oscar Health, Inc. By: /s/ Ranmali Bopitiya Name: Ranmali Bopitiya Title: Chief Legal Officer Date: January 10, 2024